Prime Medicine, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2023 | $-41.6M | $-43.6M | $2.0M | $1.7M |
| Mar 2024 | $-67.7M | $-70.0M | $2.3M | $5.2M |
| Mar 2025 | $-48.9M | $-51.3M | $2.4M | $5.7M |
| Mar 2026 | $-42.7M | $-42.9M | $214.0K | $4.6M |
A great business at a fair price is superior to a fair business at a great price.